Abstract:Drug of abuse (DOA) consumption is a growing problem worldwide, particularly with increasing numbers of new psychoactive substances (NPS) entering the drug market. Generally, little information on their adverse effects and toxicity are available. The direct detection and identification of NPS is an analytical challenge due to their ephemerality on the drug scene. An approach that does not directly focus on the structural detection of an analyte or its metabolites, would be beneficial for this complex analytical scenario and the development of alternative screening methods could help to provide fast response on suspected NPS consumption. A metabolomics approach might represent such an alternative strategy for the identification of biomarkers for different questions in DOA testing. Metabolomics is the monitoring of changes in small (endogenous) molecules (<1,000 Da) in response to a certain stimulus, e.g., DOA consumption. For this review, a literature search targeting "metabolomics" and different DOAs or NPS was conducted. Thereby, different applications of metabolomic strategies in biomarker research for DOA identification were identified: (a) as an additional tool for metabolism studies bearing the major advantage that particularly a priori unknown or unexpected metabolites can be identified; and (b) for identification of endogenous biomarker or metabolite patterns, e.g., for synthetic cannabinoids or also to indirectly detect urine manipulation attempts by chemical adulteration or replacement with artificial urine samples. The majority of the currently available literature in that field, however, deals with metabolomic studies for DOAs to better assess their acute or chronic effects or to find biomarkers for drug addiction and tolerance. Certain changes in endogenous compounds are detected for all studied DOAs, but often similar compounds/pathways are influenced. When evaluating these studies with regard to possible biomarkers for drug consumption, the observed changes appear, albeit statistically significant, too small to reliably work as biomarker for drug consumption. Further, different drugs were shown to affect the same pathways. In conclusion, metabolomic approaches possess potential for detection of biomarkers indicating drug consumption. More studies, including more sensitive targeted analyses, multi-variant statistical models or deep-learning approaches are needed to fully explore the potential of omics science in DOA testing.

Applications of Metabolomics in Forensic Toxicology and Forensic Medicine

Metabolomics in clinical and forensic toxicology, sports anti‐doping and veterinary residues

Metabonomics and its applications in forensic toxicology

Metabolomics in the field of biomedical research

Forens(om)ic medicine: omics in forensic medicine

From flesh to bones: Multi‐omics approaches in forensic science

Forensic NMR metabolomics: one more arrow in the quiver

Statistical Methods for the Analysis of High-Throughput Metabolomics Data

Computational Approaches for Systems Metabolomics

Metabolomics analysis for biomarker discovery: advances and challenges

The Potential of Metabolomics in Biomedical Applications

(Pre)Clinical Metabolomics Analysis

Omics era in forensic medicine: towards a new age

Lipidomics in forensic science: a comprehensive review of applications in drugs, alcohol, latent fingermarks, fire debris, and seafood authentication

Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology

Microbiome and Metagenome Signatures: The Potential Toolkit for Futuristic Forensic Investigations

Capabilities and drawbacks of mass spectrometry in the forensic field: analysis of real cases dealing with toxicology and explosives

Postmortomics: The Potential of Untargeted Metabolomics to Highlight Markers for Time Since Death

Recent development of metabonomics and its applications in clinical research]

Metabolomic Strategies in Biomarker Research–New Approach for Indirect Identification of Drug Consumption and Sample Manipulation in Clinical and Forensic Toxicology?